Biomarkers of Response to Systemic Treatments in FH-deficient RCC
NCT05243173
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Metabolomics
Renal Cell Carcinoma
FH-Deficient RCC
Systemic Treatments
Interventions
OTHER:
Sequencing
Sponsor
RenJi Hospital